Skip to main content
Caplight Logo









Vitadio

Vitadio

Private
PragueHealthcare & Life Scienceshttp://vitadio.com/

Last Round

Series A

Sep 25, 2023

Total Funding Raised

$4.26M

Company Overview

Vitadio is a medtech company that develops prescription digital therapeutics for lifestyle-related conditions such as type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, Telemedicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Government Contracts, Subscription SaaS

AI Layer

Application

Keywords

prescription digital therapeuticsDTxDiGAdigital health applicationdiabetes management appchronic condition managementreimbursed digital healthmedical AIlifestyle modification programmedtechpatient engagementcompanion apptelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vitadio Comparables

Compare Vitadio with similar companies based on industry and business-model similarity.

Vitadio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perfood GmbH
85%
Liva Healthcare
83%
MiGuide
82%

Vitadio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 25, 2023
SeedApr 22, 2020

Vitadio Investors

Notable investors and investment history

Vitadio investors
InvestorRounds
N1Seed
Pilulka LabSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2023

    $3.18M round led by Theras Group

  • Apr 22, 2020

    $1.08M round led by N1 and Pilulka Lab

Vitadio Filings

Explore SEC and related filing metadata, where available.

Vitadio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vitadio's valuation, stock price, and market status.

Is Vitadio a public or private company?

Vitadio is a private company.

What is the current stock price of Vitadio?

Vitadio is a private company with no public stock price. No recent secondary market data is available.

How much is Vitadio worth (valuation)?

Valuation information for Vitadio is not publicly available.

Can I buy Vitadio stock?

Vitadio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vitadio's last funding round?

Vitadio's most recent funding round was Series A on September 25, 2023.

Who are the main investors in Vitadio?

Key investors in Vitadio include N1, Pilulka Lab.

Will Vitadio IPO soon?

No public IPO plans have been announced for Vitadio.

How can I track Vitadio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vitadio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPrague
Year Founded2019
Last FundingSep 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?